Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$0.63 - $1.14 $9,798 - $17,730
-15,553 Reduced 31.76%
33,417 $27,000
Q1 2023

May 08, 2023

BUY
$1.45 - $2.95 $10,776 - $21,924
7,432 Added 17.89%
48,970 $74,000
Q4 2022

Feb 01, 2023

BUY
$2.02 - $3.25 $41,898 - $67,411
20,742 Added 99.74%
41,538 $99,000
Q2 2021

Jul 30, 2021

SELL
$2.56 - $5.49 $17,804 - $38,182
-6,955 Reduced 25.06%
20,796 $114,000
Q1 2021

May 03, 2021

BUY
$2.69 - $5.25 $32,729 - $63,876
12,167 Added 78.07%
27,751 $75,000
Q4 2019

Jan 21, 2020

SELL
$2.41 - $4.4 $26,514 - $48,408
-11,002 Reduced 41.38%
15,584 $63,000
Q1 2019

Apr 29, 2019

SELL
$2.51 - $3.73 $13,852 - $20,585
-5,519 Reduced 17.19%
26,586 $79,000
Q4 2018

Jan 25, 2019

BUY
$1.59 - $2.66 $37,353 - $62,491
23,493 Added 272.79%
32,105 $76,000
Q2 2018

Aug 06, 2018

SELL
$2.26 - $4.65 $13,385 - $27,541
-5,923 Reduced 40.75%
8,612 $20,000
Q1 2018

May 03, 2018

SELL
$3.51 - $6.04 $283,558 - $487,947
-80,786 Reduced 84.75%
14,535 $68,000
Q4 2017

Jan 31, 2018

BUY
$3.26 - $4.78 $20,795 - $30,491
6,379 Added 7.17%
95,321 $311,000
Q3 2017

Nov 08, 2017

BUY
$3.48 - $4.44 $309,518 - $394,902
88,942
88,942 $392,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.